GOSS (STOCKS)
Gossamer Bio, Inc. Common Stock
$0.172900
+0.011000 (+6.79%)
Prev close: $0.161900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Faheem Hasnain
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $82.80M
- Employees
- 145
- P/E (TTM)
- -0.21
- P/B (TTM)
- -0.24
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
5
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.20 | $-0.17 | -0.0314 | -18.62% |
|
Dec 2025 (Q4)
|
$-0.21 | $-0.20 | -0.0104 | -5.21% |
|
Sep 2025 (Q3)
|
$-0.21 | $-0.20 | -0.0144 | -7.36% |
|
Jun 2025 (Q2)
|
$-0.17 | $-0.18 | +0.0147 | +7.96% |
Financial Statements
| Assets | $128.90M |
| Current Assets | $124.54M |
| Noncurrent Assets | $4.36M |
| Fixed Assets | $59.00K |
| Other Non-current Assets | $4.30M |
| Liabilities | $290.38M |
| Current Liabilities | $56.51M |
| Accounts Payable | $10.82M |
| Wages | $12.65M |
| Other Current Liabilities | $33.04M |
| Noncurrent Liabilities | $233.88M |
| Equity | -$161.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$161.48M |
| Liabilities And Equity | $128.90M |